San Antonio, TX, United States of America

Rajiv K Satsangi

This inventor holds 1 USPTO granted patent. Top assignee: The University of Texas System. Active years: 2008.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rajiv K Satsangi. Retrieved from https://idiyas.com/inventor/rajiv-k-satsangi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2008

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Rajiv K. Satsangi: Inventor of Implant Coatings.

Introduction

Rajiv K. Satsangi is an inventor associated with San Antonio, Texas, and The University of Texas System. His work includes an invention focused on improving the compatibility and integration of implants with surrounding bone.

Latest Patents

Satsangi is credited with 1 patent, titled “Implant Coatings.” The invention describes applying a biocompatible coating to an implant, potentially incorporating bone-growth-promoting compounds such as phospholipids, bone morphogenetic proteins, or combinations of these materials. The coating is intended to encourage bone growth near the implant and support its integration with surrounding bone.

Career Highlights

Satsangi’s listed patent reflects an interest in implant technology and biomaterials. The proposed coating approach aims to improve how implants interact with the body and adjacent bone tissue.

Collaborations

His listed coworkers include Neera Satsangi and Joo L. Ong. His patent work is associated with The University of Texas System.

Conclusion

Rajiv K. Satsangi’s implant-coating invention explores how biocompatible materials may promote bone growth and improve implant integration.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…